Development in Home Mechanical Ventilation for Patient With Amyotrophic Lateral Sclerosis.
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorRigshospitalet, Denmark
About this trial
The aims of the study are to calculate the positive predictive value (PPV) of the codes for home mechanical noninvasive and invasive ventilation in patients with Amyotrophic lateral sclerosis in Denmark, and to describe the initial clinical characteristics of patients with ALS and invasive and noninvasive HMV between 2012 and 2026. Moreover, the study will describe the national development of home mechanical ventilation for patient with ALS, including calculating the incidence, prevalence and mortality of the the patients with invasive HMV. .
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with at least two hospital contacts from 2012 and 2026 with an ALS diagnosis
Patients with one hospital contacts from 2012 and 2026 with a diagnosis or procedure codes related to mechanical ventilation
Patients with one hospital contacts from 2012 and 2026 with a process marker related to mechanical ventilation (SKS, sundhedsklassifikationssystem)
Disqualifiers
None
Trial population
Patients with amyotrophic lateral sclerosis
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
Not listed
Trial groups
400 Participants
are grouped into 2 trial groupsGroup A: Invasive home mechanical ventilation
Group B: Noninvasive home mechanical ventilation
Trial outcomes
Primary outcomes
1
Positive predictive value of HMV codes for invasive HMV
Time frame
2012-20252
Positive predictive value of HMV codes for non-invasive HMV
Time frame
2012-2025Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: